Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A Single-Center Experience With Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia: A Modest Pitch for Non-Total Body Irradiation Conditioning Regimens Publisher Pubmed



Hamidieh AA1 ; Eslami Shahre Babaki A1 ; Rostami T1 ; Kasaeian A1, 2 ; Koochakzadeh L3 ; Aliabadi LS1 ; Behfar M1 ; Ghavamzadeh A1
Authors
Show Affiliations
Authors Affiliations
  1. 1. The Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. The Noncommunicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. The Department of Pediatric Hematology and Oncology, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Experimental and Clinical Transplantation Published:2019


Abstract

Objectives: Allogeneic hematopoietic stem cell trans - plantation has been used for several decades to treat patients with acute lymphoblastic leukemia. Total body irradiation has been promoted as an important component of conditioning regimens for this process; however, recent reports of chemotherapy-based conditioning regimens have shown comparable outcomes. Materials and Methods: We report our experience with radiation-free conditioning using busulfan and cyclophosphamide in 127 pediatric patients with acute lymphoblastic leukemia who were treated between 1997 and 2014. The median age was 11 years (range, < 1 to 15 y), 70% of patients were male, 81.1% received transplants from HLA-matched siblings, 83% received peripheral blood stem cells, 41% were in second complete remission at the time of transplant, and 83% had B-lineage immunophenotype. Results: In patients who were in complete remission at the time of transplant, 5-year overall survival, leukemia-free survival, and relapse rates were 62.48% (95% confidence interval, 52.29-71.09%), 49.43% (95% confidence interval, 39.57-58.53%), and 45.64% (95% confidence interval, 35.85-54.88%), respectively. We observed significant differences between outcomes in patients by time of transplant, presence of chronic graft-versus-host disease, and remission status. Conclusions: Our relapse rates were comparable to those shown in recent studies, although the transplantrelated mortality rate was lower. The results of our study showed that a busulfan/cyclophosphamide condi - tioning regimen has acceptable outcomes without the undesirable adverse effects of total body irradiation, particularly in pediatric patients. Large multicenter studies are needed to assess less toxic conditioning regimens with fewer adverse effects in these patients. © Baskent University 2019.